Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Aquestive Therapeutics Inc AQST

Healthcare
Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is developing pharmaceutical products to deliver complex molecules through administrations that are alternatives to invasive and inconvenient standard of care therapies. It is advancing a product pipeline for the treatment of severe allergic reactions, including anaphylaxis. It has also developed a product pipeline focused on... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AQST)

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

GlobeNewswire 12 days ago

Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire November 4, 2024

Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm(TM) (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American College of Allergy Asthma and Immunology (ACAAI) 2024 Annual Meeting

GlobeNewswire October 25, 2024

Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylm(TM) (epinephrine) Sublingual Film

GlobeNewswire October 24, 2024

Aquestive Therapeutics to Report Third Quarter 2024 Financial Results and Recent Business Highlights on November 4 and Host Conference Call on November 5 at 8:00 a.m. ET

GlobeNewswire October 21, 2024

Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day

GlobeNewswire September 27, 2024

Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th

GlobeNewswire September 9, 2024

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

GlobeNewswire August 22, 2024

Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm(TM)

GlobeNewswire August 14, 2024
View More News ››

Opinion & Analysis (NDAQ:AQST)

Aquestive Therapeutics Shares Up on Pipeline Update and Raised Full-Year 2019 Guidance

Streetwise Reports November 7, 2019

'Undervalued' Biopharma Features Robust Pipeline, Future Upside

Streetwise Reports April 29, 2019
View More Opinion ››

Bullboard Posts (NDAQ:AQST)

Excellent YT analysis on AQST!

https://youtu.be/0nGmma8apnE
BryceCanada - May 13, 2023

AQST - Price Drop

<< View Post To Watch Video >>
HDavis - December 21, 2021

AQST - Monday Rundown, Tuesday Expectations

<< View Post To Watch Video >>
HDavis - December 20, 2021

AQST - FDA Approval Insight

<< View Post To Watch Video >>
HDavis - December 19, 2021

AQST - FDA Approval Insight

<< View Post To Watch Video >>
HDavis - December 19, 2021

AQST - Tuesday Rundown, Wednesday Expectations

<< View Post To Watch Video >>
HDavis - November 30, 2021
View more Bullboard ››

International Lithium Corp.

International Lithium Corp.

International Lithium Corp. is a Canadian lithium exploration company. The Company's key metals are lithium (Li), copper (Cu) ...
View More »